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Over the past decade, bloodstream infections (BSI) caused by nontyphoidal Salmonella (NTS) have killed approximately 650,000 people globally1. Invasive NTS (iNTS) disease dis-
proportionally affects immunocompromised individuals such as 
adults with human immunodeficiency virus and children under 
five years of age with malaria, malnutrition or severe anaemia liv-
ing in lower-to-middle-income countries2. Recently, a systematic 
review established that Salmonella was the most frequently isolated 
pathogen in hospitalized patients diagnosed with community-onset 
BSI in Africa and Asia (2008 to 2018)3. The S. enterica serovar 
Typhimurium (S. Typhimurium) is responsible for approximately 
two-thirds of iNTS disease cases in Africa4, and consequently is a 
focal point for research.
The majority of S. Typhimurium isolated from BSI in Africa have 
sequence type ST3135. There are two distinct and tightly clustered 
lineages of ST313, which differ from each other by 455 single nucle-
otide polymorphisms (SNPs)5. ST313 lineage 1 (L1) and ST313 lin-
eage 2 (L2) differ by 700 SNPs6 from ST19, which commonly causes 
gastrointestinal infections globally. The African ST313 L1 and L2 
are genetically distinct from ST313 found in the United Kingdom 
and Latin America7,8.
It has been proposed that antimicrobial resistance (AMR) 
contributed to the success of ST313 lineages in Africa, with a large 
proportion of strains being multidrug resistant (MDR)9. Amongst 
S. Typhimurium ST313, chloramphenicol resistance is specifi-
cally found in L2, and is thought to have contributed to the clonal 
replacement of L1 by L2 prior to 2001, when chloramphenicol was 
the empirical treatment choice for suspected sepsis in Malawi6. 
Subsequently, chloramphenicol was replaced by the oral fluoro-
quinolone ciprofloxacin for treatment of iNTS infections in several 
parts of Africa including Malawi. The third-generation cephalospo-
rin ceftriaxone became the empirical therapeutic for suspected sep-
sis from 20059. More recently, variants of ST313 L2 with resistance 
to third-generation cephalosporins and ciprofloxacin or azithromy-
cin have been identified in Malawi and the Democratic Republic of 
Congo, respectively10,11.
In addition to AMR, the ST313 lineages have accumulated 
loss-of-function mutations (genome degradation)12. Evidence of 
host adaptation in ST313 involved specific pseudogenes that inac-
tivated gene function and modified metabolic and virulence phe-
notypes5,13–18. The functional relevance of genome degradation in 
ST313 has been investigated at the transcriptomic, proteomic and 
phenotypic levels for several key isolates5,13–17,19. To understand the 
evolutionary trajectory and epidemiological relevance of functional 
degradative events, a study of Salmonella genomes from a wide 
range of contemporary and historical isolates is required.
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Bloodstream infections caused by nontyphoidal Salmonella are a major public health concern in Africa, causing ~49,600 deaths 
every year. The most common Salmonella enterica pathovariant associated with invasive nontyphoidal Salmonella disease is 
Salmonella Typhimurium sequence type (ST)313. It has been proposed that antimicrobial resistance and genome degradation 
has contributed to the success of ST313 lineages in Africa, but the evolutionary trajectory of such changes was unclear. Here, 
to define the evolutionary dynamics of ST313, we sub-sampled from two comprehensive collections of Salmonella isolates from 
African patients with bloodstream infections, spanning 1966 to 2018. The resulting 680 genome sequences led to the discovery 
of a pan-susceptible ST313 lineage (ST313 L3), which emerged in Malawi in 2016 and is closely related to ST313 variants that 
cause gastrointestinal disease in the United Kingdom and Brazil. Genomic analysis revealed degradation events in important 
virulence genes in ST313 L3, which had not occurred in other ST313 lineages. Despite arising only recently in the clinic, ST313 
L3 is a phylogenetic intermediate between ST313 L1 and L2, with a characteristic accessory genome. Our in-depth genotypic and 
phenotypic characterization identifies the crucial loss-of-function genetic events that occurred during the stepwise evolution of 
invasive S. Typhimurium across Africa.
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Here we study a large and up-to-date collection of ST313, reveal-
ing the stepwise evolution of S. Typhimurium causing BSI in Africa. 
We uncover a pan-susceptible lineage (ST313 L3) with a distinct 
genome-degradation pattern, which emerged in Malawi in 2016. 
Despite the recent appearance of ST313 L3 in clinics, our core and 
accessory genome analyses reveal it to be a phylogenetic intermedi-
ate between ST313 L1 and L2. We perform genotypic and phenotypic 
characterization of the key loss-of-function events that occurred 
along the evolutionary pathway of invasive S. Typhimurium 
across Africa.
Results
Assembling an informative collection of S. Typhimurium isolates. 
A combination of historical and contemporary S. Typhimurium 
bloodstream isolates was sampled from two sources (Fig. 1). The 
main dataset consisted of 608 human bloodstream isolates collected 
between 1996 and 2018 from the Malawi–Liverpool–Wellcome 
Trust Clinical Research Programme (MLW) in Blantyre, Malawi. To 
provide context, 72 human bloodstream isolates collected between 
1966 and 2012 by the Unité des Bactéries Pathogènes Entériques, 
Institut Pasteur, Paris, France were also included. This contextual 
collection was derived from 13 countries in Africa, 1 in Europe 
and 1 in Asia. A description of the isolates is summarized in Fig. 1, 
details of sequencing quality control are available in Supplementary 
Table 1 and the complete metadata, including genome accession 
numbers, are in Supplementary Table 2.
Population structure of S. Typhimurium. To define the popula-
tion structure of S. Typhimurium currently causing BSI in Africa, 
we explored the relationship of the 680 S. Typhimurium genomes 
from the MLW and contextual collections. The two predominant 
sequence types causing BSI in Malawi were ST313 (n = 549) and 
ST19 (n = 34). A small number of isolates (n = 25) were typed as 
ST313 single-locus variants (ST3257 (n = 17), ST2080 (n = 3), 
ST302 (n = 3), ST4200 (n = 1) and ST4274 (n = 1)). The contextual 
dataset contained two sequence types, ST313 (n = 43) and ST19 
(n = 29). In sum, ST313 isolates originated from nine African coun-
tries (Fig. 1). Previous genome-based analyses of the African ST313 
epidemic included isolates from eastern and central Africa6,11. Here, 
by including several Western Africa countries, we have expanded 
the known geographic range of ST3136,8,11,20–23 to include Cameroon, 
Central African Republic, Niger, Senegal, Sudan and Togo.
To investigate population structure, a core genome 
maximum-likelihood phylogeny was constructed, and cluster des-
ignation was performed. Three major ST313 clusters, four ST19 
clusters and a small number of miscellaneous strains were identi-
fied (Extended Data Fig. 1). Multi-locus sequence type variants 
formed discrete sublineages. The three ST313 clusters were clonal, 
with cluster 1 and 2 corresponding to previously defined lineages 
(ST313 L1 and L2)5.
The genomes of contemporary isolates revealed that a third lin-
eage has been circulating in Malawi since 2016 (ST313 L3; Fig. 2). 
Characterization based on long-read sequencing showed that ST313 
L3 strain BKQZM9 had a circular chromosome (4.8 Mb) with 
99.98% sequence identity to the ST313 L2 reference strain D235805.
To fully contextualize ST313 L3, we constructed a core gene 
maximum-likelihood phylogeny, including previously published 
ST313 genomes (Supplementary Table 3), alongside the current 
dataset (Extended Data Fig. 2). ST313 L3 forms a monophyletic 
cluster within a group of ST313 strains isolated in the United 
Kingdom and Brazil7,8, raising the possibility of an international 
transmission event. ST313 L3 isolates are closely related, with a 
maximum pairwise distance of 16 SNPs. To determine whether 
ST313 L3 represents an outbreak in Malawi, it would be necessary 
to combine genome-based information with details on time, person 
and place. Patient-level GPS data were unavailable, therefore the 
geospatial distribution of ST313 L3 is currently unknown.
Accessory genome of S. Typhimurium ST313 lineages. To under-
stand the relationship between ST313 L3 and other ST313 lineages, 
we examined the accessory genome in the context of popula-
tion structure (Fig. 2). All lineages carried the virulence plasmid 
pSLT24, and ST313 L2 additionally contained plasmids pBT1, pBT2 
and pBT3, consistent with previous studies5,17. ST313 L1 carried 
a previously unreported 8,274-base pair (bp) plasmid, sharing 
99.27% sequence identity with pAnkS25 (GenBank NC_010896.1), 
which encodes the LsoA–LsoB toxin–antitoxin proteins. This 
toxin–antitoxin system functions as a bacteriophage exclusion 
system in Salmonella26 (Supplementary Discussion 1). ST313 L3 
strain BKQZM9 contained the 95 kb plasmid (pSLT), a 1,975-bp 
plasmid (pBT3) and a 2,556-bp plasmid (pBT2, identified using 
short-read data only). Thus, the plasmid profile of ST313 L3 
shared more similarity with ST313 L2 than other lineages, but 
lacked pBT1 (Fig. 2, S1).
A pairwise comparison of reference strains BKQZM9 (ST313 
L3), D23580 (ST313 L2) and U2 (the representative UK-isolated 
ST313 strain) (Extended Data Fig. 3) revealed chromosomal differ-
ences involving the prophage repertoires (Fig. 2 and Supplementary 
Information). The common S. Typhimurium prophages Gifsy-1, 
Gifsy-227 and ST64B28 were identified in all three ST313 African 
lineage reference strains. ST313 L3 carried a Fels-2-like prophage 
that was absent from the ST313 L2 and the UK-isolated ST313 rep-
resentative, and shared 99.99% sequence identity to the prophage 
RE-201029 found in other extraintestinal Salmonella serovars, includ-
ing a global outlier cluster of Salmonella Enteritidis30 and Salmonella 
Panama31,32 (Extended Data Fig. 3). Prophage BTP5 was absent from 
the ST313 L3 reference strain. BTP5 is associated with ST313 L1 and 
L233, but is generally absent from UK-isolated ST31320.
Prophage BTP1 was not found in ST313 L3, although a related 
P22-like prophage with 74% fragmented sequence identity to 
BTP1 occupied the same attachment site (Extended Data Fig. 4a). 
The P22-like prophage had almost identical replication, lysis and 
capsid genes to BTP1, differing only in the Ea, immunity, tail and 
gtr regions, and lacking the bstA34 gene. The ST313 L3 P22-like pro-
phage carried the sieB gene, which encodes a superinfection exclu-
sion phage immunity protein35. The SieB proteins of ST313 L3 and 
P22 were 92% identical, with the two proteins sharing 177 out of 192 
amino acids. Carriage of a gene that mediates abortive phage infec-
tion could confer a selective advantage to ST313 L3, reflecting the 
functional role of the BTP1 prophage-encoded BstA virus defence 
protein in ST313 L234. BstA defends bacterial cells that carry BTP1 
against exogenous attack by a variety of lytic phages, conferring a 
beneficial trait to ST313 L2 without sacrificing lytic autonomy34. 
Although BTP1 is absent from the UK reference strain U2, two 
UK-isolated ST313 strains (U15 and U87) carried a P22-like pro-
phage with 99.96% sequence identity to the one found in ST313 L3 
(Extended Data Fig. 4b). In summary, the prophage repertoire of 
ST313 L3 shares similarities with UK-isolated ST313.
Fig. 1 | Bloodstream isolates of Salmonella Typhimurium used in this study. Isolates were collected from either the Unité des Bactéries Pathogènes 
Entériques of the Institut Pasteur Centres (n = 72, light blue) or the MLW Clinical Research Center (n = 608, dark blue). Bar graphs show the number of 
isolates of different sequence types collected by centre per year. Donut charts indicate the proportion of sequence types collected per country and show 
the total number of isolates from each location in the centre. Note that only isolates from African countries (M’gascar, Madagascar; Congo, Republic of the 
Congo) are shown in donut plots. Letters in superscript relate to the location on the map. The colour code is shown at the bottom of the figure.
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Genomic epidemiology of AMR. To obtain epidemiological 
insights into the emergence of ST313 lineages, we investigated the 
dynamics of AMR. The draft genome sequences of all 680 isolates 
were examined for genes and mutations that confer reduced sus-
ceptibility to antimicrobials (Supplementary Discussion 2). In 
total, 65% (n = 440) of isolates had an MDR genotype36. Among 
ST19 isolates, only 11% (7 out of 63) of isolates were resistant to 
at least 1 antimicrobial. However, among ST313 isolates, 94% of 
isolates were resistant to at least 1 antimicrobial. The number of 
chloramphenicol-resistant isolates of ST313 L2 have decreased 
over time, with 89.19% (n = 66 out of 74) before 2005, decreasing 
to 84.11% (n = 307 out of 365) between 2006 and 2015 and 65.28% 
(n = 47 out of 72) between 2016 and 2018 (Fig. 3 and Supplementary 
Table 2). Interestingly, there have been changes in antimicrobial 
usage policy at the local level in Malawi during this timeframe, 
including the phased withdrawal of chloramphenicol from clinical 
practice beginning in 2001.
Overall, ST313 in this study had numerous genetic determinants 
of antibiotic resistance, with 29 different AMR genotype patterns 
involving 11 antimicrobials (Fig. 3). The AMR phenotype of ST313 
L1 and L2 is encoded by resistance cassettes carried on a compos-
ite Tn21-like transposable element, inserted in the S. Typhimurium 
virulence plasmid pSLT5–7,14. The plasmid backbone of pSLT was 
present in all ST313 strains and we observed lineage-specific varia-
tion in the Tn21 insertion site, consistent with previous reports5. 
The Tn21-like region varied between isolates, reflecting the AMR 
profile (Extended Data Fig. 5). Plasmid pAnkSST313-L1 carried the 
blaTEM gene which mediated beta-lactam resistance of ST313 L1.
ST313 L3 was pan-susceptible to all antimicrobials tested, both 
genotypically and phenotypically (Fig. 2), as were the UK-isolated 
ST31320. In contrast to L1 and L2, ST313 L3 did not carry an MDR cas-
sette on the pSLT-BT plasmid (Extended Data Fig. 6). Phylogenetic 
reconstruction of the pSLT plasmid (Extended Data Fig. 7) reflected 
the core genome SNP-based phylogeny, demonstrating four phylo-
genetic clades (ST313 L1, L2, L3 and ST19). There was no evidence 
of a scar associated with excision of the Tn21-like transposable ele-
ment around location 48,530 on the ST313 L3 pSLT plasmid.
Less than 1% (n = 5/180) of African S. Typhimurium ST313 L2 
carried mutations associated with reduced fluoroquinolone suscep-
tibility (for example, gyrA37), originating in Malawi (n = 3), Mali 
(n = 1) or Cameroon (n = 1). The GyrA proteins had either S83F, 
D87N or D87Y amino acid substitutions. All five strains were phe-
notypically susceptible to ciprofloxacin. Ongoing surveillance will 
be important for identification of strains with triple mutations which 
would confer full resistance to this clinically important antibiotic.
The evolutionary trajectory of S. Typhimurium ST313. Dates for 
lineage divergence were provided by Bayesian phylogenetic infer-
ence (Fig. 4 and Extended Data Fig. 8). The most-recent common 
ancestor (MRCA) of all ST19 and ST313 sampled in this study was 
from around ad 918 (95% highest posterior distribution (HPD) 
ad 570–1080) and the MRCA of all ST313 sampled in this study 
(Fig. 4, event 0) was from around ad 1566 (95% ad HPD 
1271–1953). The incorporation of historical and diverse isolates 
that predate those used in previous phylodynamic analysis6,7 gener-
ates an older MRCA of ST313 lineages than previously described7 
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Fig. 2 | The four major ST313 clusters have different prophage and plasmid repertoires. Maximum-likelihood phylogeny demonstrating the population 
structure of ST313 L1, L2 and L3. Approximate location of UK lineages is indicated schematically (Extended Data Fig. 2) due to the diversity of isolates. 
Prophage and plasmid repertoire of the reference strain for each lineage are shown (dark grey indicates presence; light grey represents absence). 
Reference isolates used were A130 (ST313 L1), D23580 (ST313 L2), BKQZM9 (ST313 L3) and U2 (UK strains). Red blocks represent the extent of 
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(around ad 1787). However, we note that the branch linked to the 
MRCA is deeply rooted in the phylogeny and the 95% HPD val-
ues reported here have a substantial range. A limitation of Bayesian 
analysis is that it relies upon a series of user-defined prior probability 
distributions that influence the estimation of tip dates (Methods).
The MRCA of ST313 L1 dated to about ad 1794 (95% HPD ad 
1738–1965), with Malawian ST313 L1 forming a discrete sublineage 
with an MRCA dating to around ad 1950 (95% HPD ad 1921–1986) 
(Fig. 4, event 1). The ST313 L2 MRCA (Fig. 4, event 2) dated to 
around ad 1948 (95% HPD ad 1929–1959). These MRCA estimates 
overlap with previous 95% HPD values for ST313 lineage dating6. 
The MRCA of ST313 L3 (Fig. 4, event 3) was ad 2007 (95% HPD 
ad 1998–2012), showing that the clonal expansion of ST313 L3 
occurred in recent evolutionary history.
Phylodynamics of pseudogene formation in S. Typhimurium 
ST313. To explore the association of pseudogenization and invasive 
salmonellosis, we characterized the stepwise progression of func-
tional gene loss associated with host adaptation that probably facili-
tated the ST313 epidemic in Africa (Methods). This phenomenon is 
exemplified by the timeline of pseudogene accumulation in ST313 
L2 shown in Fig. 4.
Our discovery of ST313 L3 allowed the timeline of 
gene-degradation events to be scrutinized in more detail. For exam-
ple, mutations in melR (F311L), flhA (A166T) and pipD (283-bp 
deletion) occurred prior to the divergence of ST313 L3 and ST313 
L2, while the mutations in bcsG (W247*), sseI (IS26 insertion) and 
lpxO (E198*) preceded the clonal expansion of ST313 L2. A small 
number of gene-degradation events were associated only with ST313 
L3, specifically an additional non-synonymous mutation in ratB 
(G820S) and a 109-bp deletion in pipD. Both mutations occurred in 
genes that had been pseudogenized earlier in evolutionary history, 
and so are unlikely to cause specific phenotypic changes. The macB, 
sseI and lpxO genes that were non-functional in ST313 L2 were func-
tional in ST313 L3, as reported previously for the UK ST313 repre-
sentative (U2)7. We recently reported the functional significance of 
the pseudogenization of macB for ST313 L218. The frameshift event 
that inactivated the macB gene occurred between ad 1948 and ad 
1953 (95% HPD ad 1931–1963), representing the final stage in the 
evolution of ST313 L2 detected in our analysis (Fig. 4).
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Fig. 3 | Temporal AMR trends in S. Typhimurium lineages (1996–2018). The combination matrix (bottom) depicts predicted AMR patterns of S. 
Typhimurium. Isolates collected before 1996 were sampled only sporadically, and thus were excluded from analysis. Within the combination matrix, dark 
grey circles indicate genome-predicted resistance and the vertical combination of grey circles represents the resistance profile. Total number of isolates 
with each resistance profile is indicated below the matrix. The combination matrix was created using the UpSetR package87. The bubble plot (top) depicts 
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Function of evolutionarily important S. Typhimurium ST313 
genes. To complement our genome-derived evolutionary insights, 
we linked a number of lineage-specific phenotypes to individual 
SNPs (summarized in Table 1 and detailed fully in Supplementary 
Table 4). For example, the KatE catalase protects bacteria from envi-
ronmental oxidative stress, and shows a maximal activity in sta-
tionary phase cultures of S. Typhimurium ST1915. The E117G KatE 
mutation caused low level catalase activity in ST313 L1, L2, L2.1 
and the UK-isolated ST3137,11,15. We report a similarly low activity in 
ST313 L3 (Table 1 and Supplementary Table 4). Catalase is required 
for biofilm formation38, a phenotype associated with survival out-
side the host, leading to the suggestion that pseudogenization of 
katE in ST313 reflects adaptation to a restricted host range16.
The red, dry and rough (RDAR)-negative phenotype of ST313 
L239 is caused by pseudogenization of bcsG15 and two nucleotide 
changes in the csgD gene promoter region39. ST313 L3 has an inter-
mediate RDAR phenotype, with an incomplete wrinkling pattern 
(Supplementary Table 4). ST313 L3 has a functional bcsG gene and 
had the same csgD-associated −189 promoter mutation as ST313 
L1 and L239. Our finding that ST313 L3 has lost traits required for 
stress resistance and biofilm formation is consistent with a reduced 
requirement for environmental survival and the mounting evidence 
for human-to-human transmission of ST31340,41.
S. Typhimurium ST19 relies on carbon metabolism to colonise 
the mammalian gastrointestinal tract42, whereas genes required for 
utilization of specific carbon sources, such as tartrate and melibiose, 
are not functional in ST313 lineages17. ST313 L3 was also unable 
to grow with tartrate or melibiose as a sole carbon source, consis-
tent with the pseudogenization of the ttdA and melR genes in both 
ST313 L3 and ST313 L25,17 (Fig. 4).
Further evidence of genome degradation is provided by the 
pseudogenization of the genes ratB in all ST313 lineages, pipD in 
ST313 L2 and L3, and lpxO in ST313 L2. The PipD effector pro-
tein has been implicated in gastrointestinal pathogenesis of ST19, 
although a causal relationship has not been demonstrated43,44. The 
lpxO gene is pseudogenized by a stop codon in ST313 L25. LpxO 
hydroxylates lipid A, a modification required for virulence of 
S. Typhimurium ST1945. We used mass spectrometry to show that 
the lack of functional LpxO caused structural modifications of lipid 
A in ST313 L2 (Table 1, Supplementary Table 4). The functionality 
of the lpxO gene in ST313 L3, reflects the distinct evolutionary path 
of this lineage.
ttdA Q68*
macB (2-bp deletion)
Plasmid pBT1
lpxO E198*
bcsG W247*
sseI (IS26 insertion)
Prophage BTP5
ratB G820S
pipD (109-bp deletion)
Prophage P22-Like
Prophage Fels2-like
ratB T885I
macB W262*
Prophage BTP1
Prophage BTP5
Plasmid pAnkS
ratB R66C
melR F311L
flhA A166T
pipD (283-bp deletion)
Plasmid pBT2
Plasmid pBT3
ratB Q657*
ratB Q1067H
katE E117G
Sequence type
ST313
2
3
1
0
0
1
3
2BTP1
2018918 1018 1118 1218 1318 1418 1518 1618 1718 1818 1918
Year
ra
tB
C
lu
st
er
S
T
ka
tE
ttd
A
m
el
R
pi
pD
flh
A
bc
sG
ss
eI
lp
xO
m
ac
B
ST19
ST3257
ST4200
RhierBAPS cluster
C1 (ST313 L1)
C2 (ST313 L2)
C3 (ST313 L3)
C4
C5
C6
Predicted functionality
Functional
Non-functional
Evolutionary events
MRCA all ST313
Clonal expansion L1
Clonal expansion L2
Clonal expansion L3
Fig. 4 | Stepwise evolution of S. Typhimurium responsible for BSi in Africa. Chronograph of 150 S. Typhimurium strains isolated from the bloodstream 
of human patients with iNTS disease. The choice of the 150 isolates from both the Malawian and contextual datasets is described in Methods. The figure 
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ST313 lineages highlighted in colour. Predicted functionality (Methods) is depicted as a colour strip for each gene and is based on whole-genome-based 
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overlying the chronograph. An asterisk represents a premature stop codon. The numbers in black circles indicate four key evolutionary events.  
Figure visualized using iTOL69.
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Invasiveness potential of ST313 L3. To determine the potential of 
ST313 L3 to cause BSI, the invasiveness index of each sample was 
calculated and compared between different ST313 lineages using 
the Wilcoxon–Mann–Whitney test46. The ‘invasiveness index’ rep-
resents the extent of genome degradation and diversifying selection 
specific to invasive serovars, using a proven set of 196 extrain-
testinal predictor genes47. Consistent with previous studies, we 
observed a significant increase in the invasiveness index of ST313 
L2 compared with ST313 L1 (W = 7,636.5, P < 0.001), and ST313 
L1 compared with ST19 (W = 552.5, P < 0.001)11,47. ST313 L3 had a 
particularly high invasiveness index (median = 0.187, s.d. = 0.008), 
which was significantly greater than that of ST19 (median = 0.110, 
s.d. = 0.017), ST313 L1 (median = 0.129, s.d. = 0.008) or ST313 
L2 (median = 0.134, s.d. = 0.006) (W = 0, P < 0.001) (Fig. 5). 
ST313 L3 also had a significantly greater invasiveness index than 
the UK-isolated ST313 (median = 0.134, s.d. = 0.018), (W = 480, 
P < 0.001).
In total, 17 of the 196 extraintestinal predictor genes had 
undergone additional degradation in ST313 L3 (isolate BKQZM9) 
compared with ST313 L2 (D23580), involving the presence of 
non-synonymous SNPs, indels or gene loss (Supplementary 
Table 5). A number of the degraded genes in ST313 L3 are required 
for colonisation of the gastrointestinal tract by S. Typhimurium 
ST19, including mrcB, a gene that allows Salmonella Typhi to sur-
vive in the presence of bile48. In S. Typhimurium, a functional damX 
gene is required for resistance to bile49, and was degraded in seven of 
the nine ST313 L3 isolates. The napA gene had extensive deletions 
in all but one of the ST313 L3 isolates, and encodes a periplasmic 
nitrate reductase required for gut colonisation17,50. Together, our 
findings suggest that ST313 L3 is in the process of adapting from an 
intestinal to a systemic lifestyle.
Clearly, this in silico approach does not prove that ST313 L3 has 
adapted to an extraintestinal lifestyle. In the past, infection models 
have provided understanding of the virulence and systemic spread 
of Salmonella pathovariants that cause gastroenteritis51. However, 
cellular and animal infection models have failed to discriminate 
between levels of invasiveness of ST313 L1 and L214 and an ST313 
sublineage identified in the Democratic Republic of Congo11. 
Although the invasiveness index cannot yet be experimentally 
validated, Salmonella isolates with different invasiveness indices 
produce distinct clinical symptoms in a human population52. The 
development and validation of experimental approaches for the 
robust measurement of the invasiveness of African S. Typhimurium 
will be an important focus for future research, but goes beyond 
the scope of this paper. Meanwhile, the ‘invasiveness index’ is a 
useful tool for monitoring the genetic signatures associated with 
invasiveness and host adaptation in ST313 lineages.
Perspective
Our data provide an expanded and contemporary insight into the 
dynamics of S. Typhimurium-associated BSI in Africa, elucidating 
the stepwise evolution of ST313. This study provides a snapshot 
of the large repertoire of genomic changes that shaped the emer-
gence of successful ST313 lineages. The stepwise pseudogeniza-
tion of genes reported here is consistent with the host adaptation 
of S. Typhimurium ST313 lineages over evolutionary history6,40 and 
Table 1 | Summary of the phenotypic impact of pseudogenes in ST313 lineages
Gene Name Description Phenotype
ratB (STM2514) Secreted outer membrane protein Inactivation of ratB is associated with gut persistence in mouse model and is 
likely to have reduced the enteric potential of ST313 (ref. 14).
katE (STM1318) Stationary phase catalase Catalase activity is reduced across all ST313 L1 and L2 isolates7,15. We 
confirmed that ST313 L3 has a lower catalase activity than ST19.
ttdA (STM3355) l(+)-tartrate dehydratase l-tartaric acid and dihydroxyacetone cannot be used as sole carbon sources by 
ST313 L1 or L2 (ref. 14). We confirmed experimentally that ST313 L3 is unable 
to grow on l-tartaric acid as a sole carbon source.
melR (STM4297) Melibiose operon response regulator ST313 L2 cannot grow on melibiose as a sole carbon source17,82. We confirmed 
experimentally that ST313 L3 was unable to grow on melibiose as a sole 
carbon source.
flhA (STM1913) Flagella biosynthesis protein Comparison of the ST313 L2 D23580 flhA474 mutant to wild type shows that 
the A166T SNP carried by ST313 L2 and ST313 L3 causes reduced motility17.
pipD (STM1094) Pathogenicity island encoded protein D Although a causal relationship is unproven, the PipD effector protein of ST19 
contributes to macrophage persistence in murine models14,17,43.
bcsG (STM3624) Cellulose biosynthetic enzyme Biofilm formation is impaired in ST313 L2 due to a mutation in bcsG15. Here we 
show that biofilm formation in ST313 L3 is also impaired. The genetic basis is 
unknown.
sseI (STM1051) Type III secretion effector protein (SPI-2) Studies in mice demonstrate that an accumulation of SNPs within the sseI gene 
of ST313 L2 increases the ability of the bacteria to disseminate rapidly from 
the gut to the draining lymph nodes16.
lpxO (STM4286) Putative membrane-bound β-hydroxylase We compared the lipid A of ST313 L2 (D23580) and ST19 (4/74) during 
growth in SPI-2-inducing media. By mass spectrometry, we confirmed that 
the lipid A of ST313 L2 lacks the LpxO-mediated modification associated with 
ST19.
macB (STM0942) Putative ABC transport protein MacAB is involved in oxidative stress resistance13 and antibiotic resistance 
to macrolides81. In ST313 L1 and L2, variants of the MacAB–TolC tripartite 
efflux pump affect replication in macrophages and influence fitness during 
colonization of the murine gastrointestinal tract18.
Associated phenotypic data are presented in Supplementary Table 4.
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supports mounting evidence for a human ST313 reservoir40. Our 
findings reflect similar patterns of evolution found in other 
Salmonella serovars that currently cause BSI disease globally. 
For example, a third of all iNTS disease cases in Africa are caused 
by S. Enteritidis which also shows signs of genome degradation 
consistent with niche adaptation30,53.
We discovered that ST313 L3 emerged in 2016 as a cause of BSI 
in the Malawian population, and had an MRCA from around ad 
2007. It is possible that the phased removal of chloramphenicol from 
clinical practice following local policy changes in Malawi between 
2002 and 2005 created a window of opportunity for the emergence 
of fully susceptible ST313 L3 (Supplementary Discussion 2). ST313 
L3 forms a monophyletic cluster within a diverse group of ST313 
originally identified in the UK7. The combination of our phyloge-
netic and accessory genome analyses led us to conclude that ST313 
L3 has been introduced into the Malawian population, probably 
via an international transmission event. Importantly, ST313 L3 had 
an elevated invasiveness index compared to ST313 L2, unlike the 
UK-isolated ST313 strains that had a lower invasiveness index than 
ST313 L247. The majority of genes unique to ST313 L3 were plasmid- 
or prophage-encoded, including by the prophage RE-201029 which 
is found in other extraintestinal Salmonella pathovariants30–32. Apart 
from accessory genome composition, other ST313 L3-specific 
changes involve loss-of-function SNPs in genes that are not required 
for systemic infection. The findings predict that ST313 L3 will be 
better adapted to cause extraintestinal infection than other ST313 
lineages from both the UK and Malawi, possibly explaining the 
emergence of ST313 L3.
Methods
Dataset. Salmonella samples were derived from two archived blood culture 
collections. The main dataset was sourced from the MLW in Blantyre, Malawi 
and consists of over 14,000 Salmonella bloodstream isolates from patients with 
iNTS disease at the Queen Elizabeth Central Hospital between 1996 and 2018. 
Isolates listed as S. Typhimurium were extracted from the metadata file for the 
entire collection and stratified by AMR profile into the following four categories: 
susceptible, resistant to one first-line agent, resistant to two first-line agents, or 
MDR. First-line agents were considered to be ampicillin, cotrimoxazole and 
chloramphenicol. Random subsampling was then performed using a random 
number generator (Excel, Microsoft) and selected samples were collected and 
resuscitated from the freezer archives at MLW. We successfully recovered 647 
isolates for whole-genome sequencing.
To complete the MLW data, a contextual dataset was sourced from the Institut 
Pasteur, Paris. The dataset consisted of 96 S. Typhimurium isolates collected from 
human extraintestinal sites from patients contaminated in Algeria, Burkina Faso, 
Cameroon, Central African Republic, Republic of the Congo, France, Côte d’Ivoire, 
Madagascar, Mali, Niger, Senegal, Sudan, Togo and Vietnam between 1966  
and 2012. All 96 S. Typhimurium samples were selected and sent for 
whole-genome sequencing.
Whole-genome sequencing of short reads. Isolates were prepared by inoculating a 
single bead of frozen Salmonella stock into a FluidX 2D Sequencing Tube (FluidX) 
containing 100 μl buffered peptone water (Oxoid, CM0509) and incubating 
overnight at 37 °C. Thermolysates were generated by heat-killing cultures in a 
95 °C water bath for 20 min before DNA extraction (MagAttract kit, Qiagen) and 
whole-genome sequencing, as part of the 10,000 Salmonella Genomes Project54 
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(https://10k-salmonella-genomes.com/). Illumina Nextera XT DNA Libraries 
were prepared (Illumina, FC-131-1096) and sequenced (Illumina HiSeq 4000) in 
multiplex (768) as 150-bp paired-end reads.
Assembly and annotation of short reads. Trimmomatic55 v0.36 was used to 
trim adapters and Seqtk v1.2-r94 (https://github.com/lh3/seqtk) was used to 
trim low-quality regions using the trimfq flag. Fastqc v0.11.5 (https://www.
bioinformatics.babraham.ac.uk/projects/fastqc/) and multiqc v1.0 (http://multiqc.
info) were used to pass sequence reads according to the following criteria: passed 
basic quality statistics, per base sequence quality, per base N content, adapter 
content and an average GC content of between 47% and 57%. Only high-quality 
reads were used in downstream analysis. Unicycler56 v0.3.0 was used to assemble 
genomes and QUAST57 v4.6.3 was used to evaluate assembly quality to standards 
consistent with Enterobase58. Specifically, N50 > 20 kb, 600 or fewer contiguous 
sequences, total number of bases between 4 Mbp and 5.8 Mbp. Prokka59 v1.12 was 
used to annotate the genomes.
Sequence typing. Serotyping was confirmed using the Salmonella In Silico Typing 
Resource60 v1.0.2 and compared with the original metadata table. The strains were 
assigned a multi-locus sequence type (MLST) using MLST61 v2.10 on the basis of 
the conservation of seven housekeeping genes.
Reference mapping to D23580. Trimmed sequencing data were mapped against 
the S. Typhimurium reference genome D23580 using BWA mem62 v0.7.10-r789. 
The reference genome consists of the D23550 chromosome (GenBank accession: 
LS997973.1), and four plasmids including pSLT-BT (accession: LS997974.1), pBT1 
(accession: LS997975.1), pBT2 (accession: LS997976.1) and pBT3 (accession: 
LS997977.1). Mapped reads were then cleaned and sorted using the SAMtools 
suite63 v1.7. Reads were realigned against the reference using GATK64 v3.7 by 
creating targets for realignment (RealignerTargetCreator) and performing 
realignment (IndelRealigner). Removal of optical duplicates was completed using 
Picard v2.10.1-SNAPSHOT (https://broadinstitute.github.io/picard/). Sequence 
variants were called using Bcftools v1.9-80 (http://samtools.github.io/bcftools) to 
generate a reference-based pseudogenome for each sample with greater than  
10× depth. QualiMap65 v2.0 was used to identify a mean sample depth of  
35.17× across all isolates.
Phylogenetic reconstruction of dataset. High-quality pseudogenomes (MLW 
n = 608, contextual n = 72) were concatenated, plasmids were excluded and 
Gubbins66 v2.2 was used to remove recombinant regions and invariable sites. The 
resultant multiple sequence alignment of reference-based pseudogenomes (12,013 
variant sites) was used to infer a maximum-likelihood phylogeny using RAxML-ng67 
v0.6.0 with 100 bootstrap replicates to assess support. To assign clusters, rhierBAPs68 
was used, specifying two cluster levels, 20 initial clusters and infinite extra rounds. 
Visualizations were performed using interactive Tree Of Life (iTOL)69 v4.2.
Phylogenetic reconstruction of dataset and publicly available dataset. For 
contextual interpretation, previously published S. Typhimurium ST313 sequences 
were retrieved from public repositories (Supplementary Table 2) and constructed 
in a core gene phylogeny with our data. Roary70 v3.11.0 was used to generate 
a core gene alignment and SNP-sites71 v2.3.3 was used to extract SNPs. The 
resultant multiple sequence alignment (15,240 variant sites) was used to construct 
a maximum-likelihood phylogeny using RAxML-ng67 v0.6.0 with 100 bootstrap 
replicates to assess branch support. Visualizations were made using iTOL69 v4.2.
Temporal phylogenetic reconstruction. To determine the evolutionary history 
of ST313, a chronogram was produced using Bayesian phylogenetic inference. 
Because the MLW collection is substantially larger than the contextual collection 
and to reduce computation time, 150/680 samples were chosen for inclusion 
in the analysis as described below. Sampling reflected original sample selection 
for this study and included all contextual isolates which passed quality control 
(n = 72) and a subset of MLW isolates randomly selected using a random number 
generator (n = 78, Microsoft Excel). A reference-mapped multiple sequence 
alignment (7,231 variant sites) was created as described above. BEAUTI72 v2.6.1 
and BEAST272 v2.6.1 were used to create and execute three independent chains 
of length 250,000,000 with 10% burn in, logging every 1,000 and accounting for 
invariant sites. We included the prior assumptions of a coalescent Bayesian skyline 
model for population growth, and a relaxed log normal clock rate to account for 
rate heterogeneity amongst branches (the full model is described in Supplementary 
Data 1). Tracer73 v1.7.1 was used to assess convergence, with all parameter effective 
sampling sizes being >200. LogCombiner72 v2.6.1 was used to combine tree files 
and DensiTree v2.2.774 was used for visualization. Finally, a maximum clade 
credibility tree was created using TreeAnnotator72 v2.6.0.
Determination of invasiveness index. The invasiveness index of each isolate 
was calculated using previously defined methods47. Because isolates used in 
our study originated from human bloodstream, we used an invasiveness index 
model that was pre-trained using a mixture of gastrointestinal and extraintestinal 
salmonellae47. Specifically, samples were analysed using 196 top predictor genes 
for measuring invasiveness in S. enterica. The machine-learning approach 
uses a random forest classifier and delta-bitscore functional variant-calling to 
discriminate between the genomes of invasive and gastrointestinal Salmonella. The 
invasiveness index has been validated using multiple Salmonella serovars, and the 
approach clearly discriminated between the S. Enteritidis and S. Typhimurium 
lineages associated with extraintestinal infections in sub-Saharan Africa11,47.  
The distribution of invasiveness index values for each lineage were compared  
using the Wilcoxon–Mann–Whitney test46 implemented through R75 v3.4.0.  
A custom-made database of the top 196 invasiveness predictor genes was then 
created from the multi-fasta file provided47. SRST276 v0.2.0 was used to flag any 
genes with mutations in ST313 L3 compared with ST313 L2. Exact mutations were 
investigated manually using MegaX77 v0.1.
AMR testing and statistical analysis. Genetic determinants for AMR were 
identified using staramr v0.5.1 (https://github.com/phac-nml/staramr) against the 
ResFinder78 and PointFinder79 databases. Phenotypic antimicrobial susceptibility 
testing was performed using the EUCAST disk diffusion method80 (Antibiotic 
discs: ampicillin 10 μg, chloramphenicol 30 μg and trimethoprim/sulfamethoxazole 
25 μg from Mast Group). To compare the results of genotypic against phenotypic 
testing, sensitivity and specificity were calculated for first-line agents used over 
the study period using MedCalc’s test evaluation calculator with Clopper–Pearson 
confidence intervals (https://www.medcalc.org/calc/diagnostic_test.php).
Genomic conservation of plasmids, prophages and pseudogenes. A literature 
search was used to identify genomic regions known to vary between ST19 and 
ST313, including plasmids5, prophages33 and pseudogenes7,13–17,43,81,82. We compiled 
a list of previously identified pseudogenes associated with the emergence of ST313 
lineages in Africa (Supplementary Table 4)14. The collection included metabolic 
genes (melR17 and ttdA14), environmentally responsive genes (bcsG15, katE15 and 
macB13), genes that modulate the bacterial cell surface (flhA17 and lpxO83) and 
virulence genes (pipD43, ratB14, sseI16). Genes of unknown function were not 
included. We detected the SNPs responsible for pseudogene formation, as well 
as other non-synonymous mutations. A custom-made database of the identified 
regions was created, along with known variants. Sequences were downloaded using 
the online tool SalComD2358017. SRST276 v0.2.0 was then used to identify alleles 
present and the non-exact matches were investigated manually using MegaX77 
v0.1. Prophage and plasmid presence or absence were manually mapped onto 
the phylogeny using iTOL69 v4.2. The conservation of pseudogene-associated 
mutations was identified at the population level and integrated into the temporal 
phylogenetic reconstruction using iTOL69 v4.2. These analyses allowed inference 
of branches in which functional gene loss and plasmid and prophage acquisition 
occurred. Phenotypic testing was conducted to determine the relevance of plasmid 
and functional gene loss as detailed in Supplementary Methods 1.
Phylogenetic reconstruction of pSLT plasmid. Plasmid sequences were 
extracted from high-quality pseudogenomes and snp-sites71 was used to extract 
SNPs. The resultant multiple sequence alignment of length 1,034 sites was used 
to infer a maximum-likelihood phylogeny using RAxML-ng67 v0.6.0 with 100 
bootstrap replicates to assess support. The phylogeny was visualized in iTOL69 and 
convenience rooted to display lineages.
Long-read sequencing of ST313 L3 reference strain BKQZM9. ST313 L3 strain 
BKQZM9 was selected for long-read sequencing as it has the highest overall quality 
statistics based on short-read sequencing. An Oxford Nanopore MinION84 9.4.1 
flowcell and SQK-RAD004 rapid sequencing kit was used with base calling by 
Guppy v3.1.5 (https://nanoporetech.com/nanopore-sequencing-data-analysis#). 
Approximately 120× coverage (600 Mb, 60,164 reads, read N50 33 kb) was 
generated. Hybrid genome assembly with the Illumina reads was done using 
Unicycler56 v0.4.4 which resulted in a 4.8-Mb circular polished chromosome 
(GenBank accession: CP060169), a 94-kb circular plasmid (pSLT) (accession 
CP060170) and a 1,975-bp circular plasmid (pBT3) (accession: CP060171). 
Prokka59 v1.12 was used for annotation as above.
Genomic comparison of ST313 lineages. To determine the basic architecture of 
the ST313 L3 BKQZM9 genome, the identity of the chromosomal and plasmid 
regions were compared with existing sequences from ST313 L1 (A130), ST313 
L2 (D23580) and ST313 UK (U2) using the Basic Local Alignment Search Tool 
(BLAST)85 and visualized using the Artemis Comparison Tool86 v13.0.0. Putative 
prophage and plasmid sequences were extracted and identified using a BLAST85 
search against known ST313 prophages and plasmids and the non-redundant 
NCBI nucleotide database. Prophage and plasmid presence or absence were also 
determined experimentally (Supplementary Discussion 2).
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
Sequence data that support the findings of this study have been deposited in 
the Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra). Accession 
NATuRE MiCRoBioLoGY | www.nature.com/naturemicrobiology
Articles NATUrE MIcrOBIOLOGy
numbers are available in Supplementary Table 2. The complete genome and 
plasmid sequence for ST313 L3 strain BKQZM9 can be found under bioproject 
ID PRJNA656707, specifically, complete chromosome (GenBank accession: 
CP060169), pSLT (GenBank Accession: CP060170) and pBT3 (GenBank 
Accession: CP060171). The following three S. enterica serovar Typhimurium 
strains are in the process of being deposited in the DSMZ strain collection: A130 
(ST313 L1), D23580 (ST313 L2) and BKQZM9 (ST313 L3). Publicly available 
sequence data were downloaded from one of the following sources: GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/), Sequence Read Archive (https://www.
ncbi.nlm.nih.gov/sra), European Nucleotide Archive (https://www.ebi.ac.uk/ena) 
or Enterobase (https://enterobase.warwick.ac.uk). Accession numbers are listed in 
Supplementary Table 3. The data summarized in Extended Data Fig. 2 are available 
in Supplementary Table 3. The remaining relevant data are within the manuscript 
and its supporting information files.
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Extended Data Fig. 1 | Dataset maximum likelihood core genome SNP phylogeny. Maximum likelihood phylogeny based on the core genome SNP 
alignment of strains used in this study. Background shading on phylogeny represents cluster designation (rHierBAPs) and additional metadata is 
represented as adjacent colour strips. Note that Malawi-Liverpool Wellcome Clinical Research Center is abbreviated to MLW and Institute Pasteur Unité 
des Bactéries Pathogènes Entériques Contextual Collection is abbreviated to IP. Figure visualised using iTOL69.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | Contextual maximum likelihood core gene SNP phylogeny. Maximum likelihood phylogeny based on the core gene SNP alignment 
of strains in this study in the context of published ST313 genomes5–8,11,21,22,89. Background shading on phylogeny represents cluster designation (rHierBAPs). 
Outer ring provides details on the original publication. Grey represents this publication. Figure visualised using iTOL69.
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Extended Data Fig. 3 | Chromosomal comparison of ST313 lineages. Comparison of the complete genome sequences of ST313 lineage representatives 
generated using the Artemis Comparison Tool86. Reference isolates used; D23580 (ST313 L2), BKQZM9 (ST313 L3) and U2 (UK strains). The number of 
genes shared between D23580 and BKQZM9 was 4,529. An additional 167 genes were BKQZM9-specific, whereas 309 genes were exclusive to D23580, 
largely explained by differences in the prophage and plasmid repertoire of the two strains. Red represents sequence similarity and white represents regions 
absent. Prophage positions are represented as coloured boxes.
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Extended Data Fig. 4 | Prophage BTP1 comparisons. Comparison of P22-like prophage regions identified in ST313 lineages generated using the Artemis 
Comparison Tool86. Red represents sequence similarity and white represents regions absent. (a) shows the comparison between P22-like prophage in 
ST313 L3 (strain BKQZM9) and ST313 L2 (strain D23580). Prophage annotation is adapted from that shown in Owen et al., 201733, with different colours 
highlighting different prophage regions. (b) shows the comparison between P22-like prophage in ST313 L3 (strain BKQZM9) and a P22-like prophage in 
ST313 sampled in the UK.
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Extended Data Fig. 5 | Examples of variation within the Tn21-like element. Annotation of the resistance cassette carried on the Tn21-like element 
integrated into the Salmonella virulence plasmid pSLT-BT. Examples of variation in the Tn21-like element is shown for three different resistance profiles in 
ST313 L2, Grey boxes between annotations represents gene presence. Annotation is adapted from Kingsley et al., 20095, and shows antibiotic resistance 
genes (red), integrase or transposase (blue), pseudogenes (green) and other genes (grey).
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Extended Data Fig. 6 | pSLT comparison of D23580 vs BKQZM9. Comparison of the Salmonella virulence plasmid pSLT identified in ST313 L3 (BKQZM9) 
and ST313 L2 (D23580) generated using the Artemis Comparison Tool86. Red represents sequence similarity and white represents absent regions. The 
location of the Tn21-like element is indicated.
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Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | Phylogenetic reconstruction of pSLT plasmid. Maximum likelihood phylogenetic tree showing the population structure of the pSLT 
plasmid in ST19 and ST313 lineages. Colour strip from right to left; cluster assignment of each isolate and number of antimicrobials each isolate is resistant 
to. The likely point of insertion of the Tn21-like element is indicated for ST313 L1 strains (green arrow) and ST313 L2 strains (blue arrow).
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Extended Data Fig. 8 | Distribution of possible hierarchies generated in BEAST analysis. Chronograph of 150S. Typhimurium strains isolated from 
bloodstream of human iNTS disease patients. The figure displays the distribution of possible hierarchies and highlights uncertainty in the timeline.  
Figure was visualized using DensiTree74.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Software used for data collection; Microsoft Excel for Mac  v 16.29.1
Data analysis Software used for data analysis is as follows; Trimmomatic v0.36, Seqtk v1.2-r94, Fastqc v0.11.5, Multiqc v1.0,  Unicycler v0.3.0 and v0.4.0,  
QUAST v4.6.3, Prokka v1.12, SISTR v1.0.2, MLST v2.10 , BWA mem v0.7.10-r789, SAMtools v1.7, GATK v3.7, Picard v2.10.1-SNAPSHOT, 
Bcftools v1.9-80,  QualiMap v2.0,  Gubbins v2.2, RAxML-ng v0.6.0,  rhierBAPs v1.1.3, Interactive Tree Of Life v4.2, Roary v3.11.0,  SNP-sites 
v2.3.3, BEAUTI v2.6.1, BEAST2 v2.6.1, Tracer v1.7.1, LogCombiner v2.6.1, DensiTree v2.2.7, TreeAnnotator v2.6.0 , R  v3.4.0, SRST2 v0.2.0,  
MegaX v0.1, staramr v0.5.1, BLAST v2.6.0, Guppy v3.1.5, Artemis Comparison Tool v13.0.0, Invasiveness Index [available at https://
github.com/Gardner-BinfLab/invasive_salmonella], Microsoft Excel for Mac  v 16.29.1. 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and 
reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
Sequence data that support the findings of this study have been deposited in the Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra). Accession numbers 
are available in Table S2. The complete genome and plasmid sequence for ST313 L3 strain BKQZM9 can be found under bioproject ID PRJNA656707, specifically 
complete chromosome (GenBank accession: CP060169), pSLT (GenBank Accession: CP060170), pBT3 (GenBank Accession: CP060171). Publicly available sequence 
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data were downloaded from one of the following sources: GenBank (https://www.ncbi.nlm.nih.gov/genbank/), Sequence Read Archive (https://
www.ncbi.nlm.nih.gov/sra), European Nucleotide Archive (https://www.ebi.ac.uk/ena) or Enterobase (https://enterobase.warwick.ac.uk). Accession numbers  for 
contextual isolates are listed in Table S3. The data underlying Figures 1, 2, 3, 4, 5, S1 and S2 are available in Table S2. Additional data underlying Figure S2 are 
available in Table S3. The remaining relevant data are within the manuscript and its supporting information files.
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Samples were derived from two archived blood culture collections to achieve the largest collection of African Salmonella Typhimurium 
bloodstream isolates sequenced to date.  
 
The main dataset was sourced from from the Malawi Liverpool Wellcome Clinical Research Programme (MLW) in Blantyre, Malawi which 
consists of ~8,000 Salmonella Typhimurium bloodstream isolates from patients with iNTS disease. Due to budgetary and staffing limitations, 
the maximum number of samples which could be whole genome sequenced was 1,000.  
 
The second collection comprised of a contextual dataset sourced from the Institut Pasteur, Paris and consists of 94 Salmonella Typhimurium 
isolates collected from human extraintestinal sites of patients. All 94 samples were sent for whole genome sequencing.
Data exclusions Data was excluded from downstream analysis in the following cases; 
 
Any bacterial sample which was unable to be resuscitated from freezer archives.  
 
Any sample which was identified as a serovar other than Salmonella Typhimurium following computational typing of genome sequence data. 
 
Any sample which failed quality control of sequence reads. Specifically if the sample failed basic quality statistics, per base sequence quality, 
per base N content, adapter content or had an average GC content out of acceptable range (47 % - 57 %). 
 
Any assembly which failed quality control. Specifically, if the sample had an N50 > 20 kb, had 600 or more contiguous sequences or the total 
number of bases was outside of acceptable range (between 4Mbp and 5.8Mbp). 
 
Any sequenced sample which failed mapping quality control. Specifically, if the mapped sample had a coverage depth less than 10x.
Replication To verify study reproducibility, the results of all automated computational approaches were confirmed either at the phenotypic level and/or 
by using multiple bioinformatic strategies. In addition, all phenotypic testing was performed in triplicate and each of the phenotypes was fully 
reproducible. To generate robust maximum likelihood phylogenetic trees, bootstrapping was used to assess branch support. Bayesian 
evolutionary analysis (BEAST) was run on three independent chains, each of length 250,000,000. All attempts at replication were successful. 
Randomization For the MLW collection, isolates listed as S. Typhimurium were extracted from the metadata file and stratified by antimicrobial resistance 
profile into the following four categories: susceptible, resistant to one first line agent, resistant to two first line agents or multi-drug resistant. 
Sub-sampling was then performed on each strata using a random number generator (Excel, Microsoft) to select 1,000 isolates. Randomization 
was not necessary for the contextual collection, as all samples were included in the study. 
Blinding Data collection was performed by a diagnostic laboratory which provided extensive metadata for each isolate to facilitate contextual 
interpretation. Consequently, blinding was not appropriate. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
3
nature research  |  reporting sum
m
ary
April 2020
Materials & experimental systems
n/a Involved in the study
Antibodies
Eukaryotic cell lines
Palaeontology and archaeology
Animals and other organisms
Human research participants
Clinical data
Dual use research of concern
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
